Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS July 18, 2018 Evolus, Inc. Announces Pricing of Public Offering of Common Stock July 16, 2018 Evolus, Inc. Announces Proposed Public Offering of Common Stock June 22, 2018 Clinical Overview of PrabotulinumtoxinA for the Investigational Treatment of Frown Lines to Be Featured During Summer Cosmetic Bootcamp 2018 View all EVENTS JMP Securities Life Sciences Conference Jun 20, 2018 at 9:00 AM EDT Cantor 2018 Dermatology & Aesthetics Summit Jun 19, 2018 at 12:00 PM EDT Jefferies 2018 Global Healthcare Conference Jun 8, 2018 at 8:00 AM EDT View all PRESENTATION June 2018 Investor Presentation
June 22, 2018 Clinical Overview of PrabotulinumtoxinA for the Investigational Treatment of Frown Lines to Be Featured During Summer Cosmetic Bootcamp 2018
